• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Wanbury Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • PPI
  • BSE Code : 2393.0
  • ISIN : INE107F01022
191.59 1 (0.56%)
  • As on 03 Nov 2026 (EOD)

  • Today’s Low

    188.50

  • Today’s High

    194.32

  • Open

    191.47

  • Perv Close

    190.52

  • 52W Low

    161.50

  • 52W High

    358.85

Key Indicators

  • P/E(TTM)

    11.35

  • Mar.Cap (₹Cr.)

    669.93

  • Div & Yield %

    0.00

  • Book Value(₹)

    41.32

  • Debt-Equity Ratio

    0.56

  • AGM Date

    03-Nov-2026

  • EPS

    16.97

  • P/E Ratio

    11.35

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    669.93

  • RONW (%)

    49.77

  • ROCE (%)

    33.46

Score Board

  • Equity (₹ in Cr.)

    34.97

  • BV (₹)

    41.30

  • Sales( ₹ in Cr.)

    650.27

  • NP (in Cr.)

    69.66

  • NP Var(%)

    145.0

  • Div%

    0.0

  • CPS (₹)

    24.00

  • EPS (₹)

    19.90

  • Traded Value (₹ in Lakhs)

    664.90

  • 52 Week High

    358.85

  • 52 Week Low

    161.50

  • Price BSE

    190.0

  • Price NSE

    191.00

  • Market Capital( in Cr.)

    664.90

  • P/C Ratio

    7.90

  • P/E Ratio

    9.50

  • Price Vs.BV

    19.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 650.27 599.51 577.74 499.65 511.19 392.52
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 650.27 599.51 577.74 499.65 511.19 392.52
Other Income 0.94 3.49 0.90 0.91 77.88 2.40
Stock Adjustments 13.00 -1.51 3.89 -29.13 24.79 7.20
Total Income 664.21 601.49 582.53 471.43 613.86 402.12
EXPENDITURE :            
Raw Materials 289.51 292.96 307.48 274.31 325.07 228.53
Power and Fuel Cost 28.59 24.24 25.17 20.59 18.41 17.13
Employee Cost 119.64 101.56 86.92 81.00 74.81 64.15
Other Manufacturing Expenses 13.63 13.76 13.32 11.43 12.66 9.98
Selling and Administration Expenses 75.68 65.92 58.71 45.16 55.34 45.49
Miscellaneous Expenses 33.07 23.15 17.93 15.45 14.36 16.42
Employee Benefit Expenses 119.64 101.56 86.92 81.00 74.81 64.15
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 560.12 521.58 509.54 447.94 500.65 381.70
Operating Profit 104.10 79.91 72.99 23.49 113.19 20.42
Interest 29.98 36.95 29.18 21.39 20.61 23.07
Gross Profit 74.12 42.96 43.81 2.10 92.58 -2.65
Depreciation 14.31 13.41 13.03 12.38 11.45 9.75
Profit Before Tax 59.81 29.55 30.78 -10.28 81.13 -12.40
Current Tax 0.65 5.86 0.00 0.00 0.00 2.27
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -6.98 -6.84 0.38 0.11 -0.35 -2.07
Reported Net Profit 66.13 30.53 30.40 -10.40 81.47 -12.61
Extraordinary Items -3.53 2.05 0.49 -0.31 76.06 1.21
Adjusted Net Profit 69.66 28.48 29.91 -10.09 5.41 -13.82
Adjustment below Net Profit -0.56 -0.38 -0.59 0.26 0.80 -0.44
P & L Balance brought forward -108.17 -138.34 -168.14 -158.01 -240.28 -227.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -42.60 -108.19 -138.34 -168.14 -158.01 -240.28
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 18.93 9.32 9.28 -3.18 24.94 -5.04
Earnings Per Share(Adj)-Unit Curr 18.93 9.32 9.28 -3.18 24.94 -5.04
Book Value 41.34 16.26 6.70 -2.26 0.57 -52.23
Book Value(Adj)-Unit Curr 41.34 16.26 6.70 -2.26 0.57 -52.23

Shareholding Pattern

  • Promoter Group

    42.98%

  • Public Share Holding

    57.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,024,000 8.65 3,024,000 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 12,005,561 34.33 12,005,561 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,005,561 34.33 12,005,561 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 521 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 249,959 0.71 249,959 8
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 853 0.00 853 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,087 0.02 7,087 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 258,420 0.74 257,899 14
2] Non Institution
Bodies Corporate 2,482,386 7.10 2,481,183 185
Clearing Members 149,342 0.43 149,342 39
Directors of their Relatives 0 0.00 0 0
Employees 46,100 0.13 46,100 1
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 629,126 1.80 627,007 299
Foreign Non Institution Other 94,680 0.27 0 1
Hindu Undivided Families 947,142 2.71 947,076 603
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,347,922 18.15 6,347,922 79
Individuals holding nominal share capital up to Rs. 1 lakh 8,336,415 23.84 8,214,143 19,181
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 384,432 1.10 384,432 6
Sub Total 19,678,947 56.28 19,458,563 20,416
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 34,966,928 100.00 34,746,023 20,432

Company Background

Wanbury LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Wanbury Ltd
  • BSE Code : 2393.0
  • ISIN : INE107F01022

  • Incorporation Year

    1988

  • Registered Office

    BSEL Tech Park B-Wing 10th Flr
    Sector 30 A Opp Vashi Rly Stat, Navi Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-67942222

  • FAX

    91-22-67942111/333

  • Chairman

  • Managing Director

  • Company Secretary

    Jitendra J Gandhi

  • Auditor

    Kapoor & Parekh Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Wanbury Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Wanbury 192.65 651.21 650.27 12.06 22.40
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77